Article

Systemic neonatal AAV9 gene therapy delivery improves behavioral and phenotypic outcomes comparable to intracerebroventricular delivery in a mouse model of Niemann-Pick disease, type C1

2025-08-19

Abstract excerpt

Niemann-Pick disease, type C (NPC), is an inherited fatal lysosomal storage disorder caused by a mutation in the NPC1 or NPC2 genes and characterized by impaired lysosomal cholesterol export. Previous studies have demonstrated that delivery of the NPC1 gene to the central nervous system (CNS) via an adeno-associated virus (AAV) can substantially improve lifespan and mitigate signs of disease in Npc1 -deficient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a2b8be38-5cdd-5e90-aa13-f3cf7ff77555
DOI: 10.1101/2025.08.15.670473

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Systemic neonatal AAV9 gene therapy delivery improves behavioral and phenotypic outcomes comparable to intracerebroventricular delivery in a mouse model of Niemann-Pick disease, type C1DOI 10.1101/2025.08.15.670473Read

Comparison of neonatal systemic and intracerebroventricular AAV9 gene therapy delivery demonstrating improved behavioral and phenotypic outcomes in a mouse model of Niemann-Pick disease, type C1.Semantic proximity Read

Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1Semantic proximity Read

Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice.Semantic proximity Read

AAV9 intracerebroventricular gene therapy improves lifespan, locomotor function and pathology in a mouse model of Niemann-Pick type C1 disease.Semantic proximity Read

Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 miceSemantic proximity Read

AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse NPC diseaseSemantic proximity Read

A Novel Small NPC1 Promoter Enhances AAV-Mediated Gene Therapy in Mouse Models of Niemann-Pick Type C1 Disease.Semantic proximity Read

Gene Therapy in a Mouse Model of Niemann–Pick Disease Type C1Semantic proximity Read

Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2.Semantic proximity Read

Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency.Semantic proximity Read

Adeno-associated viral vector serotype 9–based gene therapy for Niemann-Pick disease type ASemantic proximity Read

Endothelial and neuronal engagement by AAV-BR1 gene therapy alleviates neurological symptoms and lipid deposition in a mouse model of Niemann-Pick type C2Semantic proximity Read